Royal Bank Of Canada Molecular Partners Ag Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Nov 05, 2024
BUY
$3.73 - $5.0 $5,595 - $7,500
1,500 New
1,500 $6,000
Q1 2024

May 15, 2024
BUY
$3.73 - $5.0 $5,595 - $7,500
1,500 New
1,500 $6,000
Q1 2022

May 16, 2022
BUY
$16.51 - $31.89 $4,953 - $9,567
300 New
300 $6,000

Others Institutions Holding MOLN

# of Institutions
6
Shares Held
849K
Call Options Held
0
Put Options Held
0
View Full List

About MOLECULAR PARTNERS AG

MOLN Quotes by TradingView
  • Ticker MOLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,514,000
  • Market Cap $169M
  • Description
  • Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...
More about MOLN
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email